Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 3521-3525, June 15, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suganuma, M.
Right arrow Articles by Sugimura, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Suganuma, M.
Right arrow Articles by Sugimura, T.

Calyculin A, an Inhibitor of Protein Phosphatases, a Potent Tumor Promoter on CD-1 Mouse Skin1

Masami Suganuma, Hirota Fujiki2, Hiroko Furuya-Suguri, Shigeru Yoshizawa, Shigeru Yasumoto, Yuko Kato, Nobuhiro Fusetani and Takashi Sugimura

Cancer Prevention Division, National Cancer Center Research Institute, Tokyo 104 [M. S., H. F., H. F-S., S. Y.]; Laboratory of Molecular Oncology, Kanagawa Cancer Center Research Institute, Kanagawa 241 [S. Y.]; Faculty of Agriculture, University of Tokyo, Tokyo 113 [Y. K., N. F.]; and National Cancer Center, Tokyo 104 [T. S.], Japan

Calyculin A, isolated from a marine sponge, has a novel spiro ketal skeleton. Structurally unrelated to okadaic acid, calyculin A bound to the okadaic acid receptors in particulate and soluble fractions of mouse skin. The biochemical and tumor-promoting activities of calyculin A were studied with those of okadaic acid. Calyculin A inhibited the activity of protein phosphatases, which serve as the okadaic acid receptors. The effective dose of calyculin A for 50% inhibition was 0.3 nM, similar to that of okadaic acid. Like okadaic acid, calyculin A induced ornithine decarboxylase in mouse skin and hyperphosphorylation of a Mr 60,000 protein in human papilloma virus type 16-transformed human keratinocytes. A two-stage carcinogenesis experiment on mouse skin, initiated by 100 µg (390 nmol) of 7,12-dimethylbenz(a)anthracene and followed by 1 µg (1.0 nmol) of calyculin A, revealed that calyculin A is an additional member of the okadaic acid class of tumor promoters. The percentages of tumor-bearing mice in the groups treated with DMBA plus calyculin A, and with DMBA followed by 1 µg (1.2 nmol) of okadaic acid were 86.7 and 80.0%, respectively, in week 30. The mechanisms of action of calyculin A and okadaic acid, in addition to dinophysistoxin-1 (35-methylokadaic acid), are discussed. Calyculin A is the first tumor promoter to be screened by the okadaic acid receptor binding test.

1 This work was supported in part by Grants-in-Aid for Cancer Research from the Ministry of Education, Science and Culture and the Ministry of Health and Welfare, for a Comprehensive 10-Year Strategy for Cancer Control, Japan, and the Princess Takamatsu Cancer Research Fund.

2 To whom requests for reprints should be addressed.

Received 10/ 3/89. Revised 2/12/90.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. Buss, A. Dorrie, M. L. Schmitz, R. Frank, M. Livingstone, K. Resch, and M. Kracht
Phosphorylation of Serine 468 by GSK-3{beta} Negatively Regulates Basal p65 NF-{kappa}B Activity
J. Biol. Chem., November 26, 2004; 279(48): 49571 - 49574.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. L. McCready, B. F. Islam, F. J. Schmitz, H. A. Luu, J. F. Dawson, and C. F. B. Holmes
Inhibition of Protein Phosphatase-1 by Clavosines A and B. NOVEL MEMBERS OF THE CALYCULIN FAMILY OF TOXINS
J. Biol. Chem., February 11, 2000; 275(6): 4192 - 4198.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. Srivastava and H. B. Pollard
Molecular dissection of nucleolin's role in growth and cell proliferation: new insights
FASEB J, November 1, 1999; 13(14): 1911 - 1922.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Blank, I. Nijholt, U. Teichert, H. Kugler, H. Behrsing, A. Fienberg, P. Greengard, and J. Spiess
The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses
PNAS, December 23, 1997; 94(26): 14859 - 14864.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
S.A. Barber, C.A. Salkowski, M.J. Fultz, P-Y. Perera, R. McNally, and S.N. Vogel
Regulation of gene expression and nitric oxide production in murine macrophages by the serine/threonine phosphatase inhibitor okadaic acid
Innate Immunity, February 1, 1996; 3(1): 19 - 27.
[Abstract] [PDF]


Home page
ScienceHome page
R. Mulkey, C. Herron, and R. Malenka
An essential role for protein phosphatases in hippocampal long-term depression
Science, August 20, 1993; 261(5124): 1051 - 1055.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.